Evidence map›Paper›PMID 38582033›Full record

ArticleThe journal of nutrition, health & aging2024

Effects of a ketogenic diet on motor function and motor unit number estimation in aged C57BL/6 mice.

Carlos J Padilla, Hallie Harris, Jeff S Volek, Brian C Clark, W David Arnold

Open access · goldAbstract read
In one paragraph

Article in The journal of nutrition, health & aging, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Sex and Age-Related Changes in Lean Mass of C57BL/6 Mice: A New Method for Assessing Body Composition.Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference · 2025
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Carlos J PadillaDepartment of Kinesiology, University of Wisconsin - Madison, Madison, WI, USA. Electronic address: cpadilla4@wisc.edu.
Hallie HarrisDepartment of Plastic and Reconstructive Surgery, The Ohio State University, Columbus, OH, USA. Electronic address: hallie.harris@osumc.edu.
Jeff S VolekDepartment of Human Sciences, The Ohio State University, Columbus, OH, USA. Electronic address: volek.1@osu.edu.
Brian C ClarkDepartment of Biomedical Sciences, Ohio University, Athens, OH, USA; Ohio Musculoskeletal and Neurological Institute (OMNI), Ohio University, Athens, OH, USA. Electronic address: clarkb2@ohio.edu.
W David ArnoldUniversity of Missouri, School of Medicine, Columbia, MO, USA; NextGen Precision Health Initiative, University of Missouri System, Columbia, MO, USA. Electronic address: wdavidarnold@health.missouri.edu.
The Ohio State University · USOhio University · USUniversity of Missouri Health System · USUniversity of Wisconsin–Madison · US

Funding

Neuronal mechanisms involved in aging and ADR01AG067758 · NIA · OHIO UNIVERSITY ATHENS · PI ARNOLD, WILLIAM DAVID, CLARK, BRIAN C · 2021 to 2025
$4.1M
NIA NIH HHS R01 AG067758
6 · The paper itself

Abstract

objectivePathological, age-related loss of muscle function, commonly referred to as sarcopenia, contributes to loss of mobility, impaired independence, as well as increased risk of adverse health events. Sarcopenia has been attributed to changes in both neural and muscular integrity during aging. Current treatment options are primarily limited to exercise and dietary protein fortification, but the therapeutic impact of these approaches are often inadequate. Prior work has suggested that a ketogenic diet (KD) might improve healthspan and lifespan in aging mice. Thus, we sought to investigate the effects of a KD on neuromuscular indices of sarcopenia in aged C57BL/6 mice.

designA randomized, controlled pre-clinical experiment consisting of longitudinal assessments performed starting at 22-months of age (baseline) as well as 2, 6 and 10 weeks after the start of a KD vs. regular chow intervention.

settingPreclinical laboratory study. SAMPLE SIZE: Thirty-six 22-month-old mice were randomized into 2 dietary groups: KD [n = 22 (13 female and 9 male)], and regular chow [n = 15 (7 female and 8 male)]. MEASUREMENTS: Measures included body mass, hindlimb and all limb grip strength, rotarod for motor performance, plantarflexion muscle contractility, motor unit number estimations (MUNE), and repetitive nerve stimulation (RNS) as an index of neuromuscular junction transmission efficacy recorded from the gastrocnemius muscle. At end point, muscle wet weight and blood samples were collected to assess blood beta-hydroxybutyrate levels. STATISTICAL ANALYSIS: Primary analyses were two-way mixed effects ANOVA (diet and time × diet) to determine the effect of a KD on indices of motor function (grip, rotarod) and indices of motor unit (MUNE) and muscle (contractility) function.

resultsBeta-hydroxybutyrate (BHB) was significantly higher at 10 weeks in mice on a KD vs control group (0.83 ± 0.44 mmol/l versus 0.42 ± 0.21 mmol/l, η

conclusionKD intervention improved neuromuscular and motor function in aged mice. This pre-clinical work suggests that further research is needed to assess the efficacy and physiological effects of a KD on indices of sarcopenia.

Indexed as

AgingDiet, KetogenicMice, Inbred C57BLMuscle, Skeletal3-Hydroxybutyric AcidAnimalsFemaleMaleMiceMotor ActivityMotor NeuronsMuscle StrengthRandom AllocationSarcopenia3-Hydroxybutyric AcidAgingKetogenic dietMotor functionMotor units number estimation

Identifiers

PMID38582033
PMCPMC12275738
OpenAlexW4394006488

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.